Signifier’s eXciteOSA Receives US FDA’s Approval for the Treatment of Mild Obstructive Sleep Apnea and Snoring

February 9, 2021 Auto Bot approval, FDA, MedTech, receives 0

Shots:

  • The FDA has approved eXciteOSA to treat mild obstructive sleep apnea and snoring by using for only 20 min./day for a period of 6 wks. and then twice per week
  • In a study of 65 mild obstructive sleep apnea patients, 79% responded to therapy with 52% mean reduction in AHI, 50% reduction in ODI, 3.9point reduction in ESS. In a pivotal study, eXciteOSA achieved nearly a 40% reduction in snoring time across 115 patients
  • eXciteOSA is the first and only daytime intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring will be available in the US imminently

Click here ­to­ read full press release/ article | Ref: Businesswire | Image: Businesswire

The post Signifier’s eXciteOSA Receives US FDA’s Approval for the Treatment of Mild Obstructive Sleep Apnea and Snoring first appeared on PharmaShots.